NCT00413400 - Study of TNF-Antagonism in the Metabolic Syndrome (II) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Metabolic Syndrome

Interventions

DRUG

Etanercept

50 mg one syringe sc 2X per week for three months followed by 50 mg one syringe sc 1X per week for three months

DRUG

Placebo

50 mg one syringe sc 2x per week for three months followed by 50 mg one syringe sc 1X per week for three months

Trial Locations (1)

MGH, Boston